Other research analysts also recently issued research reports about the company. Wells Fargo & Co reiterated a buy rating and issued a $220.00 price objective on shares of Willis Towers Watson in a report on Wednesday, November 13th. Morgan Stanley dropped their price objective on Willis Towers Watson from $209.00 to $204.00 and set an overweight rating on the stock in a report on Monday, November 4th. BidaskClub downgraded Willis Towers Watson from a hold rating to a sell rating in a research note on Wednesday, October 30th. Finally, Barclays set a $235.00 price target on Willis Towers Watson and gave the stock a buy rating in a research note on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of $200.92.
Shares of WLTW traded down $0.45 during mid-day trading on Thursday, reaching $188.50. The company’s stock had a trading volume of 3,718 shares, compared to its average volume of 588,899. Willis Towers Watson has a 12-month low of $144.13 and a 12-month high of $200.93. The stock has a market cap of $24.40 billion, a PE ratio of 19.37, a price-to-earnings-growth ratio of 1.60 and a beta of 0.81. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.41 and a quick ratio of 1.41. The company’s 50 day moving average is $187.77 and its 200 day moving average is $189.31.
In other Willis Towers Watson news, insider Joseph Gunn sold 3,214 shares of the stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $185.59, for a total transaction of $596,486.26. Following the completion of the sale, the insider now directly owns 18,436 shares of the company’s stock, valued at approximately $3,421,537.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicolas Aubert sold 7,592 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $195.00, for a total value of $1,480,440.00. Following the sale, the insider now directly owns 5,875 shares of the company’s stock, valued at $1,145,625. The disclosure for this sale can be found here. Company insiders own 0.75% of the company’s stock.
Institutional investors have recently bought and sold shares of the business. Corient Capital Partners LLC acquired a new stake in shares of Willis Towers Watson in the 3rd quarter valued at approximately $218,000. Great Lakes Advisors LLC acquired a new stake in shares of Willis Towers Watson in the 3rd quarter valued at approximately $734,000. Harel Insurance Investments & Financial Services Ltd. lifted its holdings in shares of Willis Towers Watson by 445.7% in the 3rd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 2,565 shares of the financial services provider’s stock valued at $495,000 after buying an additional 2,095 shares during the period. AE Wealth Management LLC lifted its holdings in shares of Willis Towers Watson by 48.0% in the 3rd quarter. AE Wealth Management LLC now owns 3,077 shares of the financial services provider’s stock valued at $594,000 after buying an additional 998 shares during the period. Finally, BBVA USA Bancshares Inc. acquired a new stake in shares of Willis Towers Watson in the 3rd quarter valued at approximately $261,000. 94.04% of the stock is owned by institutional investors.
About Willis Towers Watson
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. The company's Human Capital and Benefits segment offers actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services.
Featured Article: Book Value Per Share – BVPS
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Willis Towers Watson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willis Towers Watson and related companies with MarketBeat.com's FREE daily email newsletter.